2Katiyar SK, Matsui MS, Mukhtar H. Ultraviolet-B exposure of human skin induces cytochromes P450 1A1 and 1BI[J]. J Invest Dermatol,2000,114(2):328-333.
3Villard PH, Sampol E, Elkaim JL,et al. Increase of CYP1B1 transcription in human keratinocytes and HaCaT cells after UV-B exposure[J]. Toxicol Appl Pharmacol,2002, 178(3):137-143.
4Gonzalez MC, Marteau C, Franchi J, et al. Cytochrome P450 4A11 expression in human keratinocytes: effects of ultraviolet irradiation[J]. Br J Dermatol,2001,145(5):749-757.
5Chandra D, Kale RK. Influence of gamma-rays on the mouse liver cytochrome P450 system and its modulation by phenothiazine drugs[J]. Int J Radiat Bio1,1999,75 (3):335-349.
6Chung HC, Kim SH, Lee MG, et al. Mitochondrial dysfunction by gamma-irradiation accompanies the induction of cytochrome P450 2El (CYP2E1) in rat liver[J]. Toxicology,2001,161(1-2):79-91.
7Goeptar AR, te Koppele JM, van Maanen JM, et al.Oneelectron reductive bioactivation of 2,3,5,6-tetramethylbenzoquinone by cytochrome P450 [J].Biochem Pharmacol,1992,43(2):343-352.
8Patterson LH.Rationale for the use of aliphatic N-oxides of cytotoxic anthraquinones as prodrug DNA binding agents: a new class of, bioreductive agent [J].Cancer Metastasis Rev,1993,12(2):119-134.
9Raleigh SM, Wanogho E, Burke MD, et al.Rat cytochromes P450 (CYP) specifically contribute to the reductive bioactivation of AQ4N, an alkylaminoanthraquinone-di-N-oxide anticancer prodrug[J].Xenobiotica, 1999,29( 11): 1115-1122.
10Patterson LH, Murray GI.Tumour cytochrome P450 and drug activation[J].Curr Pharm Des, 2002,8(15): 1335-1347.
3Hernberg M,Virkkunen P, Maasiha P, et al. Pulmonary toxicity after radiotherapy in primary breast cancer patients: results from a randomized chemotherapy study [ J]. Int J Radiat Oncol Biol Phys,2002,52 (1) :128 -136.
4Markman M, Kennedy A, Webster K, et al. Paclitaxel-assoeiated hypersensitivity reactions: experience of the gynecologic oneology program of the Cleveland Clinic Cancer Center [ J]. J Clin Oncol,2000, 18(1) :102 -105.
5Kwa SL,Lebesque JV,Theuws JC,et al.Radiation pneumonitis as a function of mean lung dose:an analysis of pooled data of 540 patients[J].Int J Radiat Oncol Biol Phys,1998,42(l):l-9.
6Hareyama M,Satoh M,Yamagishi M,et al.Radiation tolerance of normal lung pulmonary radiation syndrome[J].Gan No Rinsho,1990,36(13):2319-2325.
7Hernberg M,Virkkunen P,Maasilta P,et al.Pulmonary toxicity after radiotherapy in primary breast cancer patients:results from a randomized chemotherapy study[J].Int J Radiat Oncol Biol Phys,2002,52(1):128-136.
8Onish H,Kuriyama K,Yamaguchi M,et al.Concurrent two-dimensional radiotherapy and weekly docetaxel in the treatment of stage III non-small cell lung cancer:a good local response but no good survival due to radiation pneumonitis[J].Lung Cancer,2003,40(1):79-84.
9Lind PA,Marks LB,Hardenbergh PH,et al.Technical factors associated with radiation pneumonitis after local +/-regional radiation therapy for breast cancer[J].Int J Radiat Oncol Biol Phys,2002,52(1):137-143.
10Krueger EA,Fraass BA,McShan DL,et al.Potential gains for irradiation of chest wall and regional nodes with intensity modulated radiotherapy[J].Int J Radiat Oncol Biol Phys,2003,56(4):1023-1037.
